The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Advaxis Inc. | COM NEW | 7624208 | 5,591 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| Advaxis Inc. | W EXP 07/15/201 | 7624117 | 1,749 | 112,500 | SH | SOLE | 112,500 | 0 | 0 | ||
| Alcobra Ltd | SHS | M2239P109 | 7,294 | 1,115,315 | SH | SOLE | 1,115,315 | 0 | 0 | ||
| Aldeyra Therapeutics Inc | COM | 01438T106 | 1,054 | 135,800 | SH | SOLE | 135,800 | 0 | 0 | ||
| Ampio Pharmaceuticals Inc. | COM | 03209T109 | 8,098 | 3,388,322 | SH | SOLE | 3,388,322 | 0 | 0 | ||
| Aptose Biosciences Inc | COM NEW | 03835T200 | 102 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| Bio Blast Pharma Ltd | SHS | M20156101 | 2,330 | 338,110 | SH | SOLE | 338,110 | 0 | 0 | ||
| Caladrius Biosciences Inc | COM | 128058104 | 1,870 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| Corbus Pharmaceuticals HLDGS | COM | 21833P103 | 5,390 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| Evoke Pharma Inc | COM | 30049G104 | 291 | 55,660 | SH | SOLE | 55,660 | 0 | 0 | ||
| Galmed Pharmaceuticals Ltd | SHS | M47238106 | 654 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| Keryx Biopharmaceuticals Inc. | COM | 492515101 | 1,996 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| Lion Biotechnologies Inc | COM | 53619R102 | 890 | 97,100 | SH | SOLE | 97,100 | 0 | 0 | ||
| Medivation, Inc. | COM | 58501N101 | 251,117 | 2,198,919 | SH | SOLE | 2,198,919 | 0 | 0 | ||
| Newlink Genetics Corp | COM | 651511107 | 4,535 | 102,437 | SH | SOLE | 102,437 | 0 | 0 | ||
| OHR Pharmaceutical Inc | COM NEW | 67778H200 | 515 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
| Abeona Therapeutics Inc | COM | 00289Y107 | 6,880 | 1,359,767 | SH | SOLE | 1,359,767 | 0 | 0 | ||
| Synthetic Biologics Inc. | COM | 87164U102 | 9,692 | 3,400,816 | SH | SOLE | 3,400,816 | 0 | 0 | ||
| Zosano Pharma Corp | COM | 98979H103 | 145 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||